Pneumocystis jirovecii pneumonia (PJP) is an opportunistic fungal infection affecting immunocompromised patients. The disease is prevalent in patients with HIV, but its incidence has risen in recent decades, and it now affects more patients not infected by HIV than those infected with it.

There may be a major drug interaction, resulting in serious bleeding, between commonly prescribed medications for patients with AFib, according to a study published in the May 14, 2024, issue of JAMA.

Lauren Howell, PharmD

In its June 2024 issue, the published a multi-society guideline for the management of hypertrophic cardiomyopathy (HCM). It builds upon a 2020 guideline, offering clinicians several revisions and new recommendations to consider, including guidance about a new class of medication, genetic factors to take into account for patients, and contraindications for treatment.

Olivia C. Welter, PharmD

For patients already coping with OUD, pain management during hospitalization can pose additional risks. An article in the May 2024 issue of NEJM Evidence offers clinicians recommendations for managing acute pain in hospitalized patients with OUD who are already being treated with buprenorphine.

Elizabeth Briand

The American Society of Health-System Pharmacists (ASHP) recently released the 2023 National Survey of Pharmacy Practice in Hospital Settings, revealing significant advancements in hospital pharmacy operations.

Aiya Almogaber, PharmD